Riskpilot← Back to searchSign inGet full accessUnikulma Oy
OYActiveY-tunnus 2152639-4Petikontie 4Retail sale of medical and orthopaedic goods · NACE 4774Est. 2007— employees
Revenue 2024
EUR 11,1M
-10% vs 2023
EBITDA margin
3.2%
-67% vs 2023
Equity ratio
77.2%
Financial strength
Net profit 2024
EUR 189K
-68% vs 2023
| Revenue | EUR 11,1M | -10% |
| EBITDA | EUR 353K | -67% |
| Net profit | EUR 189K | -68% |
| Total assets | EUR 3,3M | +1% |
| Equity | EUR 2,5M | +8% |
| Employees | — | — |
Legal name
Unikulma Oy
Y-tunnus number
2152639-4
Legal form
Osakeyhtiö
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
29. lokakuuta 2007
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on kaikki laillinen toiminta.
Address
Petikontie 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 248 | 480 | 13 617 | 12 360 | 11 063 |
| Staff expenses | −180 | −110 | −769 | −863 | −859 |
| EBITDA | 0 | −1 | 2 118 | 1 072 | 353 |
| Depreciation & amort. | — | — | −37 | −34 | −27 |
| EBIT | 0 | −1 | 2 082 | 1 038 | 326 |
| Net financials | — | 0 | 2 | 10 | 31 |
| Profit before tax | 0 | −1 | 1 964 | 748 | 237 |
| Tax | 0 | −0 | 420 | 152 | 48 |
| Net profit | 0 | −1 | 1 544 | 596 | 189 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 59 | 87 | 3 860 | 3 260 | 3 295 |
| Equity | 17 | 16 | 2 760 | 2 356 | 2 545 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 42 | 71 | 1 101 | 682 | 751 |
| Total debt | 42 | 71 | 1 101 | 904 | 751 |
EBITDA margin
3.2%
This company
15.8%
Market median
-80% vs market
20202024
Equity ratio
77.2%
This company
38.2%
Market median
+102% vs market
20202024
Return on equity
7.4%
This company
18.4%
Market median
-60% vs market
20202024
Net profit margin
1.7%
This company
8.1%
Market median
-79% vs market
20202024
Asset turnover
3.36×
This company
1.12×
Market median
+200% vs market
20202024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HK Chief Executive Officer | Chief Executive Officer | 2026 |
AM Deputy Member | Deputy Member | 2019 |
| Former (3) | ||
JI Deputy Member | Deputy Member | 2007 – 2019 |
JA | Audit | 2013 – 2019 |
TJ Audit | Audit | 2019 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2007 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ortobed Oy
Unikulma Oy Board members of Unikulma Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hanna Katariina Vilhelmiina Pollock | Chief Executive Officer | 0 companies |
| Juha Ilkka Ensio Tuominen | Deputy Member | 0 companies |
| Janne Antero Rajalahti | Audit | 0 companies |
| Anne Maria Tuominen | Deputy Member | 0 companies |
| Turo Juhani Koila | Audit | 0 companies |
| Vesa Pekka Tuominen | Board of Directors | 0 companies |